The Signum Surgical logo features bold black Signum Surgical text on the left and a circular, abstract green and yellow swirl design on the right.
Find a Surgeon
Contact Us

Company News

Signum Surgical Recognized by MedTech Strategist as a “Start-Up to Watch”

MedTech Strategist: Signum Surgical Advances Unique Solution for an Overlooked Problem Signum Surgical is featured in the July/August 2026 issue of MedTech Strategist as one of the publication’s “Start-Ups to Watch.” The in-depth profile highlights the company’s innovative approach to

Learn More

What’s Going On: Hope for Patients Living with Anal Fistula

Philadelphia, PA – iHeartRadio Interviews Dr. Philip Pearson about Anal Fistula and BioHealx In an episode of What’s Going On, Loraine Ballard Morrill speaks with Dr. Philip Pearson, colorectal surgeon, educator, and social media personality known as the “Singing Surgeon,”

Learn More

Signum Surgical Appoints Medical Device Veteran Mark J. Foley as Chairman

Proven industry leader joins as company expands commercial growth of its BioHealx® technology Innovative medical technology, with FDA De Novo 510(k) clearance, for the treatment of anal fistulas   Galway, Ireland — 23 April 2026 — Signum Surgical, a commercial-stage

Learn More

Signum Surgical Publishes Positive First-in-Human Results for BioHealx® Anal Fistula Device

GALWAY, Ireland--(BUSINESS WIRE)--Signum Surgical, a medical technology company dedicated to advancing the treatment of colorectal diseases, today announced the publication of first-in-human clinical data for its BioHealx® Anal Fistula Device in the International Journal of Colorectal Disease. The results support
Learn More

Signum Surgical Appoints Carol Burns as CEO

Signum Surgical, (‘Signum’ or ‘the Company’) the medical technology company developing innovative solutions to treat colorectal diseases, is pleased to announce the appointment of Ms. Carol Burns as Chief Executive Officer.
Learn More

Signum Surgical granted FDA De Novo clearance for BioHealx™

Signum Surgical (‘Signum’ or ‘the Company’), a medical technology company developing innovative solutions to treat colorectal diseases, is pleased to announce that its BioHealxTM technology has been granted marketing clearance by the U.S. Food and Drug Administration (FDA), as a
Learn More

Signum Surgical Completes Clinical Trial for BioHealx

Signum Surgical, headquartered in Galway, is compiling data for a De Novo classification request to the U.S. FDA for its novel surgical option addressing anal fistula, a painful colorectal condition. The completion of a single-arm, non-randomized clinical trial, treating 32
Learn More

Signum Surgical granted new US patent for BioHealx

Signum Surgical, a medical technology company based in Galway, Ireland, has been granted a new US patent for its BioHealxTM device, extending its intellectual property protection in the key US market. This marks a significant milestone for the company's innovative
Learn More

Signum Surgical Secures Additional €2.9 Million Investment

Signum Surgical, headquartered in Galway, Ireland, has successfully raised an additional €2.9 million to support its ongoing regulatory submissions and clinical programs for the commercialization of BioHealxTM, a breakthrough technology designed to treat anal fistula. This financing round was led
Learn More

Dr Bernard Collins Appointed to the Board of Directors

On April 7, 2021, in Galway, Ireland, Signum Surgical, a medical technology company specializing in innovative solutions for colorectal diseases, announced the appointment of Dr. Bernard Collins as a Non-Executive Director of the Board. Dr. Collins, renowned in the medical
Learn More
Load More

Contact Us

Please get in touch with us using this form.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*
Consent*